Bill
Bill > S480
US S480
US S480National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
summary
Introduced
02/12/2015
02/12/2015
In Committee
03/16/2016
03/16/2016
Crossed Over
Passed
Dead
01/03/2017
01/03/2017
Introduced Session
114th Congress
Bill Summary
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016 (Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to: allow grants to be used to maintain existing state controlled substance monitoring programs; require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees; require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request; require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and expand the program to include any commonwealth or territory of the United States. The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes. HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs. A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.
AI Summary
This bill, the National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016, extends and revises a federal program that provides grants to states for controlled substance monitoring programs, which track prescription drug history to help identify and prevent addiction and drug diversion. The bill allows these grants to be used for maintaining existing state programs, requires states to report on how their systems connect with federal programs and health technology, and mandates that states provide data for program evaluation. It also expands eligibility for these grants to U.S. commonwealths and territories, and allows non-identifiable prescription data from these monitoring programs to be shared for research purposes. Furthermore, states receiving grants must ensure prescribers and dispensers can easily use the monitoring systems and be educated on their benefits.
Committee Categories
Health and Social Services
Sponsors (13)
Jeanne Shaheen (D)*,
Richard Blumenthal (D),
Sherrod Brown (D),
Susan Collins (R),
Dick Durbin (D),
Dianne Feinstein (D),
Kirsten Gillibrand (D),
Joe Manchin (I),
Ed Markey (D),
Chuck Schumer (D),
Jeff Sessions (R),
Pat Toomey (R),
Elizabeth Warren (D),
Last Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 440. (on 04/27/2016)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...